Bunnage Mark E. sold VRTX
February 17, 2026 · Form 4 insider transaction
Bunnage Mark E. sold 2,437 shares of Vertex Pharmaceuticals Incorporated at $489.46 per share, a transaction worth $1.19M. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
2,437
Price
$489.46
Total value
$1.19M
InsiderBunnage Mark E.
Role—
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateFebruary 17, 2026
Filing dateFebruary 19, 2026
Shares owned after9,668
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
Transaction made pursuant to Dr. Bunnage's company approved trading plan under Rule 10b5-1, which was entered into on 11/26/2025.